A survey of state public health laboratories for pertussis diagnostics

Laboratory Medicine

Volumn 38, Issue 3, 2007, Pages 169-171

  Massay, Stephanie C ^a  

^a Alaska State Public Health Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41449103304     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/FQ1P6U4E6QJ0HFAD     Document Type: Article

References (17)

1. Pertussis - United States, 1997-2000. Morbidity and Mortality Weekly Report, Vol 51. Atlanta, GA: Centers for Disease Prevention and Control; 2002; 73-76.
2. Cherry JD. Pertussis in preantibiotic and revaccine era, with emphasis on adult pertussis. Clinl Infecs Diseases. 1999;28:S107-111.
3. Bisgard K. Chapter 8 - Pertussis. Vaccine Preventable Diseases Surveillance Manual. 3rd Edition. 2002.
4. Loeffelholz M. Bordetella. In: Murray P, ed. Manual of Clinical Microbiology. Vol 1: ASM Press;2003:780-788.
5. Fry N, Neal S, Harrison TG, et al. Genotypic variation of Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun. 2001;69:5520-5528.
6. Nygren M, Reizenstein E, Ronaghi M, et al. Polymorphism in the pertussis toxin promoter region affecting DNA based diagnosis of Bordetella infection. J Clin Microbiol. 2000;38:55-60.
7. Douglas E, Coote J, Parton R, et al. Identification of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cyclase gene. J Med Microbiol. 1993;38:140-144.
8. Kosters K, Riffelmann M, Wirsing von Konig CH, et al. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. J Mel Microbiol. 2001;50:436-440.
9. Van der Zee A, Agterberg C, Peeters M, et al. Polymerase chain reaction assay for pertussis: Simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol. 1993;31:2134-2140.
10. Wadowsky RM, Michaels R, Libert T, et al. Multiplex PCR-based assay for detection of Bordetella pertussis in nasopharyngeal swab specimens. J Clin Microbiol. 1996;34:2645-2649.
11. Pertussis. Epidemiology and Prevention of Vaccine-Preventable Diseases. 8th Edition. Centers for Disease Prevention and Control, 2005;75-88.
12. Pfaller M. Molecular approaches to diagnosing and managing infectious diseases: Practicality and cost. Emerg Infect Dis. 2001;7:312-318.
13. Murphy T, Bisgard K, Sanden G. Guidelines for the control of pertussis outbreaks. Centers for Disease Control and Prevention. 2000:2-3.
14. Yih WK, Silva EA, Ida J, et al. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis. 1999;5:441-43.
15. U.S. Department of Health and Human Services Food and Drug Administration, Center for Devices and Radiological Health. Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests; Draft Guidance for Industry and FDA Reviewers. March 12, 2003.
16. Clinical and Laboratory Standards Institute. Molecular Diagnostic Methods for Infectious Disease; Approved Guideline, 2nd Edition. MM3-A2, 2006.
17. Muldermans G, Soetens O, Antoine M, et al. External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J Clin Microbiol. 2005;43:30-35.